An investigation into pathogen-specific factors required for drug-resistance and viability of Candida albicans [ 2012 - 2014 ]

Research Grant

Researchers: A/Pr Ana Traven (Principal investigator) ,  Dr Travis Beddoe ,  Prof Trevor Lithgow

Brief description We identified proteins required for growth and drug resistance of the fungus Candida albicans, a major hospital-acquired human pathogen. Candida infections target the immunocompromised and mortality is huge (?30-50%). We will use cell biology, genetics and biochemistry to characterise these proteins. Importantly, these factors are present in fungi, but absent from humans. Therefore our study will help development of new strategies for antifungal treatments.

Funding Amount $AUD 337,614.21

Funding Scheme Project Grants

Notes Standard Project Grant